Rebus Holdings, Inc. (RBSH)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 11, 2025

Rebus Holdings Company Description

Rebus Holdings, Inc., together with its subsidiaries, focuses on the research and development of precision therapeutics for the treatment of cancer.

Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally.

Rebus Holdings, Inc. was incorporated in 2003 and is based in Westlake Village, California.

Rebus Holdings, Inc.
CountryUnited States
Founded2003
IndustryBiotechnology
SectorHealthcare
Employees1
CEORaul Silvestre

Contact Details

Address:
2629 Townsgate Road
Westlake Village, Delaware 91361
United States
Phone818 597 7552
Websiterebus-corp.com

Stock Details

Ticker SymbolRBSH
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS75619J1034
SIC Code2836

Key Executives

NamePosition
Raul Silvestre Esq.Chief Executive Officer, Chief Financial Officer, President, Principal Accounting Officer and Director
Dr. John T. Isaacs Ph.D.Co-Founder, Chairman of Scientific Advisory Board and Chief Scientific Advisor
Dr. Samuel R. Denmeade M.D.Co-Founder, Chief Clinical Advisor and Member of Scientific Advisory Board